Lockheed Martin burned cash in Q1 2026 while paying out a compounder's multiple

---

There is a particular comfort that attaches to Lockheed Martin in an investor's mind. It is the prime contractor on the F-35, the most expensive weapons program in human history. It carries a record backlog. It has raised its dividend for more than two decades without interruption. It is, in the shorthand of the income-investor letters, a "sleep-well" stock — a wide-moat compounder backed by the full faith and credit of the United States Treasury, geared to a defense budget that politicians of both parties seem incapable of cutting. That is the story. The first-quarter 2026 results, reported on April 23, 2026, are an invitation to test whether the story still describes the company or merely its reputation.

The headline numbers were not catastrophic, and that is precisely why they are worth dwelling on. Revenue came in at $18.0 billion, essentially flat against the year-ago quarter. Earnings per share were $6.44, down about 12% from a year earlier. Segment operating profit was $1.8 billion, down from the prior year. Consolidated operating margin compressed to roughly 11%, from 13% twelve months earlier. None of that, on its own, would frighten a long-term holder. But the cash-flow line should give pause: free cash flow for the quarter was negative $291 million. A company the market treats as a cash machine generated, in the opening three months of 2026, less cash than it consumed.

The cash machine that didn't make cash

Free cash flow is the number that ultimately funds the dividend and the buyback — the two pillars of the "compounder" thesis. So when a quarter turns it negative, the right response is not to wave it away as timing but to ask precisely what the timing represents and whether it recurs. Management attributed the Q1 2026 figure of negative $291 million to working capital and the timing of billings, and reaffirmed full-year 2026 free-cash-flow guidance of $6.5 billion to $6.8 billion. That guidance, if hit, would be a perfectly respectable year. The forensic question is what has to go right in the remaining three quarters to bridge from a negative start to a number north of $6.5 billion.

The bridge is steep. To average into that full-year range, Lockheed has to generate the entire year's free cash flow — and then some — in the final nine months, against a backdrop in which its own executives have flagged sustained cash drag from classified programs. The defense-prime business has always been lumpy on a quarterly basis; large milestone payments and contract billings do not arrive evenly. That is the bull's defense, and it is partially fair. But "lumpy" cuts both ways. A business that can swing to negative free cash flow in a quarter is, by definition, not the metronome the multiple implies. The market pays a premium for predictability. The cash statement is telling you the predictability is thinner than the dividend record suggests.

A growth engine bolted to a single airframe

Look at where Lockheed's growth actually comes from and the concentration is stark. In full-year 2025, total sales rose about 6%, or roughly $1.6 billion — and of that increase, approximately $1.9 billion was attributable to the F-35 program alone, through higher production and sustainment volume. Read that twice. The company's entire net sales growth, and then some, came from one airplane; the rest of the portfolio, in aggregate, was a drag that the F-35 had to overcome. The F-35 did not merely lead growth. It was the growth.

That is a magnificent franchise and a profound dependency in the same breath. Lockheed delivered 191 F-35s in 2025, a record, smashing the prior high of 142. The Department of Defense and Lockheed have finalized a production agreement covering roughly 296 aircraft across Lots 18 and 19, with deliveries beginning in 2026. The fiscal-2027 budget request contemplates raising U.S. F-35 procurement toward 85 aircraft. The order book is real and deep. But a company whose growth rides on a single platform is exposed to the politics, the technical setbacks, and the cost dynamics of that single platform in a way a diversified industrial is not. When one program is the growth, the program's problems become the company's problems with no offset.

And the program has problems. The F-35's Technology Refresh 3 modernization has been dogged by delays. Sustainment costs — the lifetime bill to keep the fleet flying — remain the chronic sore point in every Government Accountability Office review of the program. The unit economics of production and the politics of the annual buy quantity are perennial negotiations, not settled facts. None of this is fatal. All of it is concentration risk wearing the costume of a moat.

The charges that keep not being one-offs

Here is the forensic heart of the matter — the quality-of-earnings question that the "safe compounder" framing studiously avoids. Lockheed has, across recent years, absorbed a procession of charges on fixed-price development programs, and the market has been trained to file each one under "non-recurring." Examine the sequence and the word starts to strain.

In full-year 2024, the company recorded roughly $2.0 billion of pre-tax losses tied to classified programs — a hit of about $6.16 to earnings per share. In the second quarter of 2025, it booked another classified-program loss of about $950 million at the Aeronautics segment. That is not one event; that is a pattern. And the pattern has a structural cause: fixed-price development contracts. On a fixed-price deal, the contractor — not the government — eats the overrun when a hard, classified, leading-edge program costs more to develop than the bid assumed. Lockheed bid these programs to win them. The bills are now arriving.

The genuinely revealing detail came on the Q1 2026 call. Management noted, in effect, that the first quarter was the first "clean" quarter in a while with no new classified charge — and then, in the same breath, guided to roughly $500 million to $700 million a year of cash burn on classified programs in 2026 and again in 2027. Sit with that. The "non-recurring" charges are now recurring guidance. The company is telling investors to expect half a billion to seven hundred million dollars a year of cash drain from programs it cannot fully describe, on contracts whose terms it cannot renegotiate at will. When a one-time item shows up in the forward outlook two years running, it is not a one-time item. It is a cost of doing business that the adjusted-earnings narrative keeps trying to exclude.

The denominator illusion

Now to the mechanism that keeps the per-share story looking serene while the business absorbs these blows: the buyback. Lockheed returns enormous sums to shareholders. In the third quarter of 2025 alone it returned roughly $1.8 billion through dividends and repurchases, and it raised its repurchase authorization by $2 billion to a $9 billion total. The dividend has now grown for 23 consecutive years; the most recent increase was about 5%. This is, to be clear, a real return of real cash, and income investors are right to value it.

But understand what the buyback does to the optics. Earnings per share is earnings divided by share count. When the share count falls, EPS can rise — or merely hold — even as the numerator, total net earnings, stalls or shrinks. Q1 2026 is a clean illustration: EPS fell about 12%, yes, but that decline understates the deterioration in the underlying profit because a smaller share base was cushioning the per-share line. The buyback is doing exactly what buybacks are designed to do — flatter the per-share metric and transfer the pressure off the income statement and onto a cash statement that fewer people read. For a company funding repurchases while free cash flow goes negative in a quarter and management guides to years of classified cash burn, the buyback is not a sign of strength so much as a sign that capital is being routed to the line item investors watch most and the line item they watch least is where the strain shows.

Cyclical demand priced as a secular certainty

The bull case rests on an unspoken premise: that the U.S. defense budget only goes up. There is a fiscal-2027 request reported at around $1.5 trillion — described as the largest in U.S. history — and it boosts procurement for the F-35 and other platforms. That is the wind at Lockheed's back, and it is real wind. But a budget request is not an appropriation, and a record top-line number is not the same as record procurement dollars flowing to legacy primes.

Defense spending is cyclical and political, not a law of nature. Topline budgets can rise while the mix shifts — toward munitions, toward space, toward software and autonomy, toward the new entrants the Pentagon has been courting precisely because it wants to break the cost curve of programs like the F-35. The "plateauing budget" risk is not that the number falls; it is that the number stops compounding at the rate baked into a defense-prime multiple, and that an increasing share of each marginal dollar is steered away from the manned, exquisite, fixed-price platforms that define Lockheed's franchise. A company priced as though its end market grows secularly forever is mispriced if that end market is merely large and cyclical.

Demonstration versus deployment: the NGAD signal

The single most consequential strategic event of the past year was something Lockheed did not win. In March 2025 the Air Force awarded its Next Generation Air Dominance crewed fighter — the F-47 — to Boeing, in a development contract valued at roughly $20 billion. For the prime that has owned U.S. air-superiority stealth since winning the Joint Strike Fighter two decades ago, losing the next-generation crewed fighter is not a footnote. It is the franchise's succession plan being handed to a rival.

Lockheed's response was to declare it would "supercharge" the F-35, taking technology from its losing NGAD bid and folding it into the existing airframe — CEO Jim Taiclet framing the ambition as delivering "80% of sixth-generation capability at 50% of the cost," a "Ferrari" upgrade to the fighter it already builds. That is a perfectly rational pivot. It is also, read forensically, a tell. A company that loses the next platform and answers by promising more from the current one is a company whose growth runway is now defined by extending a 25-year-old program rather than by winning the program that replaces it. The demonstration of next-generation ambition lives, for now, in a press release and a slogan. The deployment lives in someone else's hangar. Investors paying a secular-growth multiple are paying for a future that the Air Force, in its most important recent decision, awarded to Boeing.

Margins the company cannot reprice

The Q1 2026 margin compression deserves its own examination because it exposes a structural vulnerability that the backlog headline conceals. Aeronautics — the F-35 segment — saw sales slip about 1% and profit fall on unfavorable adjustments to the F-16 and C-130 programs. Operating margin across the company dropped to roughly 11% from 13%. Crucially, those margins sit below peers: in the same quarter, RTX posted around 13% and Northrop Grumman around 12% at the operating line. The premier defense prime is, on profitability, trailing its rivals.

The reason is the same fixed-price exposure that drives the classified charges. On a large fraction of Lockheed's mature, complex programs, the price is set and the cost is not. Inflation in materials and labor, technical rework, schedule slips — these flow straight to Lockheed's margin, because the contract structure denies it the ability to pass them through. A cost-plus contractor shares overruns with the customer. A fixed-price developer absorbs them. Lockheed's portfolio carries enough fixed-price development that margin compression and lump-sum charges are recurring features, not aberrations. You can have a record backlog and still earn a shrinking margin on it. The backlog tells you about volume. The margin tells you about quality, and the quality is drifting the wrong way.

Concentration in the customer, too

It is not only program concentration; it is customer concentration. The overwhelming majority of Lockheed's revenue derives, directly or indirectly, from a single buyer: the U.S. government, plus the allied governments that purchase under U.S.-administered programs. That buyer sets the budget, writes the contract terms, chooses the next platform, audits the costs, and can — as the NGAD award demonstrated — hand the future to a competitor at will. A supplier whose growth, margins, and next-generation prospects all sit at the discretion of one customer has negotiating leverage that is structurally capped, no matter how essential its current products are. The moat protects today's franchise. It does not give Lockheed power over the customer who decides tomorrow's.

What the bulls genuinely get right

A short thesis that does not concede the strength of the long case is propaganda, and there is a genuinely strong long case here that deserves a fair hearing. Lockheed's backlog is a record $194 billion — multiple years of revenue contracted and visible, a buffer no consumer-cyclical or software name can match. The F-35 is not a speculative bet; it is in serial production, delivered a record 191 units in 2025, and sits at the center of a finalized roughly-296-aircraft Lot 18/19 agreement with deliveries beginning in 2026 and a fiscal-2027 request lifting U.S. buys toward 85 jets. International demand, sharpened by a more dangerous world, is real and growing. The F-35 will be flown, sustained, and upgraded for decades, and Lockheed owns that recurring sustainment stream — arguably a better annuity than the production it gets credit for.

The capital return is real and durable: 23 straight years of dividend growth, a recent 5% raise, a $9 billion repurchase authorization, and full-year 2025 free cash flow guided to $6.6–6.8 billion, which would be the strongest since 2021. Full-year 2026 guidance was reaffirmed at $8.4–8.7 billion of segment operating profit and $6.5–6.8 billion of free cash flow — a company guiding up, not down, for the year as a whole. The Missiles and Fire Control segment grew sales and operating profit roughly 8% in Q1 2026, a reminder that the munitions side of the portfolio is genuinely benefiting from the restocking of Western arsenals. And the classified charges, however ugly, may prove to be the back of a difficult development cycle rather than its middle. If 2026 is the year the charges stop and the F-35 production rate climbs, today's compressed margin is a trough, not a trend. Bulls who buy on that bet are not being foolish; they are buying a real franchise on a real backlog at a moment of cyclical earnings pressure.

Priced for the serene story

The valuation question is whether the price reflects the franchise or the fairy tale. Lockheed trades at the multiple of a secular compounder — and on backlog, dividend record, and the indispensability of the F-35, that multiple is defensible at first glance. But a compounder multiple embeds an assumption of smooth, predictable, growing free cash flow. The first quarter of 2026 delivered negative free cash flow. Management's own outlook embeds $500–700 million a year of classified cash burn through 2027. Margins trail peers and are compressing. The next-generation crewed fighter went to a rival. Growth is welded to one aging airframe. Each of these is survivable. Together they describe a business that is lumpier, more concentrated, and more cyclically exposed than the multiple admits.

The asymmetry, then, is unflattering. If everything goes right — charges end, F-35 rates climb, the budget compounds, the buyback grinds the share count lower — the holder earns the modest, steady return a defense prime should deliver, and not much more, because that outcome is already in the price. If any of it goes wrong — another classified charge, a budget mix that starves manned platforms, a sustainment cost scandal, a free-cash-flow year that misses — the multiple, not just the earnings, is at risk. You are paid for perfection and exposed to lumps. That is the opposite of what "sleep-well" is supposed to mean.

The kicker

None of this makes Lockheed a fraud, a failing business, or a short you bet the farm on. It is a great franchise priced as a serene one, and the gap between those two adjectives is the whole trade. The backlog is real, the F-35 is real, the dividend is real — and so is the negative-free-cash-flow quarter, the recurring "non-recurring" charge that now lives in forward guidance, the margin that trails its rivals, and the next fighter that went to Boeing. The market has decided to read the first list and ignore the second. Forensic investors read both, and then they ask the only question that matters: at this multiple, are you being paid enough for a single-airframe growth story whose own management is guiding you to expect years of cash burn it would rather you file under "one-time"?

A record backlog tells you how much Lockheed will sell; the negative-cash-flow quarter, the recurring classified charge baked into 2027 guidance, and the lost next-generation fighter tell you how little the market is paying you to bear what could go wrong — and that, not the dividend streak, is the number that should keep a careful owner awake.